A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab

Clinical trial NCT02124850 · TERMINATED

Trial details

NCT number: NCT02124850
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2014-10-28
Primary completion: 2016-08-11
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.